284 related articles for article (PubMed ID: 33713485)
1. Effect of spironolactone and benazepril on furosemide-induced diuresis and renin-angiotensin-aldosterone system activation in normal dogs.
Adin D; Atkins C; Wallace G; Klein A
J Vet Intern Med; 2021 May; 35(3):1245-1254. PubMed ID: 33713485
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs.
Lantis AC; Ames MK; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
J Vet Pharmacol Ther; 2015 Feb; 38(1):65-73. PubMed ID: 25224804
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic assessment of diuretic efficacy and braking in a furosemide continuous infusion model.
Adin D; Atkins C; Papich MG
J Vet Cardiol; 2018 Apr; 20(2):92-101. PubMed ID: 29483040
[TBL] [Abstract][Full Text] [Related]
4. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
Ames MK; Atkins CE; Lee S; Lantis AC; zumBrunnen JR
Am J Vet Res; 2015 Dec; 76(12):1041-50. PubMed ID: 26618728
[TBL] [Abstract][Full Text] [Related]
5. The effect of enalapril on furosemide-activated renin-angiotensin-aldosterone system in healthy dogs.
Lantis AC; Ames MK; Werre S; Atkins CE
J Vet Pharmacol Ther; 2015 Oct; 38(5):513-7. PubMed ID: 25771846
[TBL] [Abstract][Full Text] [Related]
6. Comparison between the effects of torsemide and furosemide on the renin-angiotensin-aldosterone system of normal dogs.
Potter BM; Ames MK; Hess A; Poglitsch M
J Vet Cardiol; 2019 Dec; 26():51-62. PubMed ID: 31809955
[TBL] [Abstract][Full Text] [Related]
7. Role of electrolyte concentrations and renin-angiotensin-aldosterone activation in the staging of canine heart disease.
Adin D; Kurtz K; Atkins C; Papich MG; Vaden S
J Vet Intern Med; 2020 Jan; 34(1):53-64. PubMed ID: 31769114
[TBL] [Abstract][Full Text] [Related]
8. Effect of benazepril and robenacoxib and their combination on glomerular filtration rate in dogs.
Panteri A; Kukk A; Desevaux C; Seewald W; King JN
J Vet Pharmacol Ther; 2017 Jan; 40(1):44-56. PubMed ID: 27302598
[TBL] [Abstract][Full Text] [Related]
9. Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs.
Sotillo S; Ward JL; Guillot E; Domenig O; Yuan L; Smith JS; Gabriel V; Iennarella-Servantez CA; Mochel JP
Sci Rep; 2023 Feb; 13(1):2684. PubMed ID: 36792677
[TBL] [Abstract][Full Text] [Related]
10. Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs.
Mochel JP; Peyrou M; Fink M; Strehlau G; Mohamed R; Giraudel JM; Ploeger B; Danhof M
J Vet Pharmacol Ther; 2013 Apr; 36(2):174-80. PubMed ID: 22568394
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.
Mochel JP; Fink M; Peyrou M; Soubret A; Giraudel JM; Danhof M
Pharm Res; 2015 Jun; 32(6):1931-46. PubMed ID: 25446774
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Ames MK; Atkins CE; Eriksson A; Hess AM
J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
[TBL] [Abstract][Full Text] [Related]
13. Differences in the duration of diuretic effects and impact on the renin-angiotensin-aldosterone system of furosemide in healthy dogs.
Hori Y; Ohshima N; Kanai K; Hoshi F; Itoh N; Higuchi S
J Vet Med Sci; 2010 Jan; 72(1):13-8. PubMed ID: 19893284
[TBL] [Abstract][Full Text] [Related]
14. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
Lantis AC; Atkins CE; DeFrancesco TC; Keene BW; Werre SR
Am J Vet Res; 2011 Dec; 72(12):1646-51. PubMed ID: 22126693
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive characterization of the effect of mineralocorticoid receptor antagonism with spironolactone on the renin-angiotensin-aldosterone system in healthy dogs.
Masters AK; Ward JL; Guillot E; Domenig O; Yuan L; Mochel JP
PLoS One; 2024; 19(2):e0298030. PubMed ID: 38394253
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition.
Ames MK; Atkins CE; Lantis AC; zum Brunnen J
J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320316633897. PubMed ID: 27009288
[TBL] [Abstract][Full Text] [Related]
17. Effect of benazepril, robenacoxib and their combination on glomerular filtration rate in cats.
King JN; Panteri A; Graille M; Seewald W; Friton G; Desevaux C
BMC Vet Res; 2016 Jun; 12(1):124. PubMed ID: 27338786
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST).
Coffman M; Guillot E; Blondel T; Garelli-Paar C; Feng S; Heartsill S; Atkins CE
J Vet Intern Med; 2021 Jul; 35(4):1673-1687. PubMed ID: 34028078
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
[TBL] [Abstract][Full Text] [Related]
20. Effect of furosemide and high-dosage pimobendan administration on the renin-angiotensin-aldosterone system in dogs.
Ames MK; Atkins CE; Lantis AC; Werre SR
Am J Vet Res; 2013 Aug; 74(8):1084-90. PubMed ID: 23879846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
